FSM Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,677
Closed -$231K 355
2026
Q1
$231K Buy
3,677
+52
+1% +$4.16K 0.03% 291
2025
Q4
$346K Sell
3,625
-5,333
-60% -$523K 0.05% 214
2025
Q3
$875K Buy
8,958
+793
+10% +$82.1K 0.12% 101
2025
Q2
$848K Buy
8,165
+1,036
+15% +$105K 0.14% 101
2025
Q1
$719K Buy
7,129
+457
+7% +$46K 0.16% 84
2024
Q4
$655K Buy
6,672
+195
+3% +$17.2K 0.16% 82
2024
Q3
$543K Buy
6,477
+327
+5% +$25.8K 0.14% 88
2024
Q2
$474K Buy
6,150
+57
+0.9% +$4.17K 0.16% 87
2024
Q1
$417K Buy
6,093
+7
+0.1% +$450 0.15% 97
2023
Q4
$352K Buy
6,086
+8
+0.1% +$427 0.15% 107
2023
Q3
$321K Sell
6,078
-24
-0.4% -$1.26K 0.16% 103
2023
Q2
$320K Sell
6,102
-1,493
-20% -$78K 0.16% 112
2023
Q1
$380K Hold
7,595
0.22% 95
2022
Q4
$351K Hold
7,595
0.25% 91
2022
Q3
$294K Buy
7,595
+156
+2% +$6.26K 0.24% 101
2022
Q2
$305K Buy
+7,439
New +$303K 0.3% 83

Other funds holding BSX

FSM Wealth Advisors's BSX Position: Q2 2026 in Review

FSM Wealth Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,677 shares — an estimated $231K sold.

FSM Wealth Advisors first reported a position in BSX in Q2 2022 and held it in 16 quarters. The position peaked at $875K in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • FSM Wealth Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • FSM Wealth Advisors sold 3,677 Boston Scientific shares in Q2 2026, an estimated $231K.
  • FSM Wealth Advisors first reported a position in Boston Scientific in Q2 2022 and held it in 16 quarters.
  • FSM Wealth Advisors's Boston Scientific position peaked at $875K in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.